ChemicalBook > CAS DataBase List > TCY-NH2

TCY-NH2

Product Name
TCY-NH2
CAS No.
327177-34-4
Chemical Name
TCY-NH2
Synonyms
TCY-NH2;M.W. 739.87 C40H49N7O7;trans-Cinnamoyl-YPGKF-NH2;TRANS-CINNAMOYL-YPGKF-AMIDE;trans-Cinnamoyl-YPGKF-NH2, tcY-NH2;TRANS-CINNAMOYL-TYR-PRO-GLY-LYS-PHE-NH2;Protease-Activated Receptor-4, PAR-4 Antagonist, amide - 1 mg;trans-Cinnamoyl-Tyr-Pro-Gly-Lys-Phe-amide trifluoroacetate salt;L-Phenylalaninamide, N-[(2E)-1-oxo-3-phenyl-2-propen-1-yl]-L-tyrosyl-L-prolylglycyl-L-lysyl-
CBNumber
CB4157102
Molecular Formula
C40H49N7O7
Formula Weight
739.86
MOL File
327177-34-4.mol
More
Less

TCY-NH2 Property

storage temp. 
−20°C
form 
Powder
Water Solubility 
Soluble to 1 mg/ml in water
More
Less

Safety

Safety Statements 
22-24/25
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Tocris
Product number
1488
Product name
tcY-NH2
Packaging
1
Price
$219
Updated
2021/12/16
Usbiological
Product number
256892
Product name
tcY-NH2
Packaging
1mg
Price
$466
Updated
2021/12/16
TRC
Product number
N394025
Product name
tcY-NH2
Packaging
1mg
Price
$200
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
PEP0004622
Product name
TCY-NH2
Purity
95.00%
Packaging
5MG
Price
$495.5
Updated
2021/12/16
ApexBio Technology
Product number
B5123
Product name
tcY-NH2
Packaging
1mg
Price
$322
Updated
2021/12/16
More
Less

TCY-NH2 Chemical Properties,Usage,Production

Uses

tcY-NH2 does not cause aggregation but blocks aggregation caused by receptor-activating peptide analogs (GY-NH2, AY-NH2), and thrombin without affecting ADP-mediated aggregation.

in vivo

tcY-NH2 (tail vein injection, 0.6 mg/kg for a single dose) alleviates liver injury in Brain death (BD) rat model, indicated by lower serum ALT/AST levels and better histomorphology[3].
tcY-NH2 (intraperitoneal injection, 0.6 mg/kg for a single dose) increases posttraumatic activation of CD4+ Tregs within the draining lymph nodes in burn injury mice model [4].
tcY-NH2 (intrapleural injection, 40 ng/kg for a single dose) inhibits neutrophil recruitment in experimental inflammation in mice[6].

Animal Model:Brain death (BD) rat model[3]
Dosage:0.6 mg/kg for a single dose
Administration:Tail vein injection for a single dose
Result:Reduced blood platelet activation and hepatic platelet accumulation.
Attenuated the inflammatory response and apoptosis in the livers.
Inhibited the activation of NF-κB and MAPK pathways induced by Brain death (BD).
Animal Model:Burn injury model of C57BL/6 N mice[4]
Dosage:0.6 mg/kg for a single dose
Administration:Intraperitoneal injection
Result:Increased expression and phosphorylation of PKC-θ in the presence of platelets, without affecting early posttraumatic hemostasis.
Animal Model:BALB/c mice[6]
Dosage:40 ng/kg for a single dose
Administration:Intrapleural injection
Result:Abolished the number of rolling and adhering neutrophils on the vessel wall.
Inhibited CXCL8- and Cg-induced neutrophil migration into the pleural cavity of mice.

IC 50

PAR4

storage

Store at -20°C

TCY-NH2 Preparation Products And Raw materials

Raw materials

Preparation Products

327177-34-4, TCY-NH2Related Search:


  • TCY-NH2
  • TRANS-CINNAMOYL-TYR-PRO-GLY-LYS-PHE-NH2
  • TRANS-CINNAMOYL-YPGKF-AMIDE
  • M.W. 739.87 C40H49N7O7
  • trans-Cinnamoyl-Tyr-Pro-Gly-Lys-Phe-amide trifluoroacetate salt
  • trans-Cinnamoyl-YPGKF-NH2, tcY-NH2
  • trans-Cinnamoyl-YPGKF-NH2
  • L-Phenylalaninamide, N-[(2E)-1-oxo-3-phenyl-2-propen-1-yl]-L-tyrosyl-L-prolylglycyl-L-lysyl-
  • Protease-Activated Receptor-4, PAR-4 Antagonist, amide - 1 mg
  • 327177-34-4
  • C40H49N7O7
  • C40H50N7O7
  • Proteinase-activated receptor (PAR)